Genomtec S.A. Capital Reinvestment Ratio

Latest as of December 2024: 0.05x

Genomtec S.A. capital reinvestment ratio. Genomtec S.A. (GMT) has a Capital Reinvestment Ratio of 0.05x as of December 2024, meaning it reinvests 0% of its operating cash flow (zł925.00K) in capital expenditures (zł45.00K). Check cash flow reinvestment rate of Genomtec S.A. to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.05x

Capex / Operating Cash Flow

Operating Cash Flow

zł925.00K

PLN

Capital Expenditures

zł45.00K

PLN

Data as of

Dec 2024

Most recent filing

Genomtec S.A. Capital Reinvestment Ratio by Year (None–None)

Genomtec S.A. capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see GMT operating cash flow.

Year	Reinvestment Ratio	Operating CF (PLN)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow